These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34613357)

  • 1. One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration.
    Kashani AH; Lebkowski JS; Rahhal FM; Avery RL; Salehi-Had H; Chen S; Chan C; Palejwala N; Ingram A; Dang W; Lin CM; Mitra D; Pennington BO; Hinman C; Faynus MA; Bailey JK; Mohan S; Rao N; Johnson LV; Clegg DO; Hinton DR; Humayun MS
    Transl Vis Sci Technol; 2021 Aug; 10(10):13. PubMed ID: 34613357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration.
    Kashani AH; Lebkowski JS; Rahhal FM; Avery RL; Salehi-Had H; Dang W; Lin CM; Mitra D; Zhu D; Thomas BB; Hikita ST; Pennington BO; Johnson LV; Clegg DO; Hinton DR; Humayun MS
    Sci Transl Med; 2018 Apr; 10(435):. PubMed ID: 29618560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical Method for Implantation of a Biosynthetic Retinal Pigment Epithelium Monolayer for Geographic Atrophy: Experience from a Phase 1/2a Study.
    Kashani AH; Uang J; Mert M; Rahhal F; Chan C; Avery RL; Dugel P; Chen S; Lebkowski J; Clegg DO; Hinton DR; Humayun MS
    Ophthalmol Retina; 2020 Mar; 4(3):264-273. PubMed ID: 31786135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration.
    Kashani AH; Lebkowski JS; Hinton DR; Zhu D; Faynus MA; Chen S; Rahhal FM; Avery RL; Salehi-Had H; Chan C; Palejwala N; Ingram A; Dang W; Lin CM; Mitra D; Martinez-Camarillo JC; Bailey J; Arnold C; Pennington BO; Rao N; Johnson LV; Clegg DO; Humayun MS
    Stem Cell Reports; 2022 Mar; 17(3):448-458. PubMed ID: 35120620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Subretinally Administered Palucorcel for Geographic Atrophy of Age-Related Macular Degeneration: Phase 2b Study.
    Heier JS; Ho AC; Samuel MA; Chang T; Riemann CD; Kitchens JW; Slakter JS; Leiderman YI; Spencer R; Williams GA; Hickson-Curran SB; Keane M; Baldassarre JS;
    Ophthalmol Retina; 2020 Apr; 4(4):384-393. PubMed ID: 32033908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.
    Schwartz SD; Regillo CD; Lam BL; Eliott D; Rosenfeld PJ; Gregori NZ; Hubschman JP; Davis JL; Heilwell G; Spirn M; Maguire J; Gay R; Bateman J; Ostrick RM; Morris D; Vincent M; Anglade E; Del Priore LV; Lanza R
    Lancet; 2015 Feb; 385(9967):509-16. PubMed ID: 25458728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study.
    Mettu PS; Allingham MJ; Cousins SW
    Ophthalmol Sci; 2022 Mar; 2(1):100086. PubMed ID: 36246181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience With a Subretinal Cell-based Therapy in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration.
    Ho AC; Chang TS; Samuel M; Williamson P; Willenbucher RF; Malone T
    Am J Ophthalmol; 2017 Jul; 179():67-80. PubMed ID: 28435054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aflibercept for neovascular age-related macular degeneration.
    Sarwar S; Clearfield E; Soliman MK; Sadiq MA; Baldwin AJ; Hanout M; Agarwal A; Sepah YJ; Do DV; Nguyen QD
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011346. PubMed ID: 26857947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration.
    Yeong JL; Loveman E; Colquitt JL; Royle P; Waugh N; Lois N
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013154. PubMed ID: 33331670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subretinal implantation of a monolayer of human embryonic stem cell-derived retinal pigment epithelium: a feasibility and safety study in Yucatán minipigs.
    Koss MJ; Falabella P; Stefanini FR; Pfister M; Thomas BB; Kashani AH; Brant R; Zhu D; Clegg DO; Hinton DR; Humayun MS
    Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1553-1565. PubMed ID: 27335025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy.
    Petrus-Reurer S; Bartuma H; Aronsson M; Westman S; Lanner F; Kvanta A
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.
    da Cruz L; Fynes K; Georgiadis O; Kerby J; Luo YH; Ahmado A; Vernon A; Daniels JT; Nommiste B; Hasan SM; Gooljar SB; Carr AF; Vugler A; Ramsden CM; Bictash M; Fenster M; Steer J; Harbinson T; Wilbrey A; Tufail A; Feng G; Whitlock M; Robson AG; Holder GE; Sagoo MS; Loudon PT; Whiting P; Coffey PJ
    Nat Biotechnol; 2018 Apr; 36(4):328-337. PubMed ID: 29553577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28.
    Cukras C; Agrón E; Klein ML; Ferris FL; Chew EY; Gensler G; Wong WT;
    Ophthalmology; 2010 Mar; 117(3):489-99. PubMed ID: 20079925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years.
    Spielberg L; Leys A
    Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):943-56. PubMed ID: 20204659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principal Cause of Poor Visual Acuity after Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 23.
    Okeagu CU; Agrón E; Vitale S; Domalpally A; Chew EY; Keenan TDL;
    Ophthalmol Retina; 2021 Jan; 5(1):23-31. PubMed ID: 33045457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration.
    Mehat MS; Sundaram V; Ripamonti C; Robson AG; Smith AJ; Borooah S; Robinson M; Rosenthal AN; Innes W; Weleber RG; Lee RWJ; Crossland M; Rubin GS; Dhillon B; Steel DHW; Anglade E; Lanza RP; Ali RR; Michaelides M; Bainbridge JWB
    Ophthalmology; 2018 Nov; 125(11):1765-1775. PubMed ID: 29884405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic stem cell trials for macular degeneration: a preliminary report.
    Schwartz SD; Hubschman JP; Heilwell G; Franco-Cardenas V; Pan CK; Ostrick RM; Mickunas E; Gay R; Klimanskaya I; Lanza R
    Lancet; 2012 Feb; 379(9817):713-20. PubMed ID: 22281388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outer retinal tubulation formation and clinical course of advanced age-related macular degeneration.
    Arrigo A; Aragona E; Battaglia O; Saladino A; Amato A; Borghesan F; Pina A; Calcagno F; Hassan Farah R; Bandello F; Battaglia Parodi M
    Sci Rep; 2021 Jul; 11(1):14735. PubMed ID: 34282240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.